Trial site
Ege University Medical Faculty
- 14running trials
- 15closed trials
The trials here
What the 29 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Ulcerative colitis4 trials
- Haemophilia3 trials
- Chronic myeloid leukaemia2 trials
- Multiple sclerosis2 trials
- Myelodysplastic syndromes2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Chronic lymphocytic leukaemia1 trial
- Crohn's disease1 trial
- Cytomegalovirus infection1 trial
- and 10 more
- Phase
- Phase 320 trials
- Phase 24 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Status
- Completed11 trials
- Active, not recruiting10 trials
- Terminated4 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC6 trials
- Hoffmann-La Roche5 trials
- Pfizer3 trials
- Takeda2 trials
- Abivax S.A.1 trial
- and 12 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting
Active, not recruiting
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic myeloid leukaemia1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple sclerosis1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Completed
Terminated
Completed
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
Completed
Terminated
Terminated
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026